Abstract
Background: Gestational diabetes can alter the trajectory of fetal development, but there are few studies on the effects of abnormal lipid metabolism on physical development of infants. We aimed to explore the prevalence of maternal dyslipidemia, its influencing factors and effects on the physical development of fetuses and infants, as well as the role of leptin in this process. Methods: Questionnaire surveys and main outcome measures were administered among 338 pairs of pregnant women and newborns. Results: The detection rate of maternal dyslipidemia was 31.5%. The median levels of TG (triglyceride) and TG/HDL (high-density lipoprotein) ratio were higher in large-for-gestational-age (LGA) newborns. Birth weight was positively related to infants’ height and weight at six months and one year old (p < 0.05). Leptin was positively related to TG levels of pregnant women and newborns’ birth weight (p < 0.05). Logistic regression analysis showed that having greater than or equal to four meals a day (OR = 6.552, 95%CI = 1.014–42.338) and liking to eat lightly flavored food during pregnancy (OR = 1.887, 95%CI = 1.048–3.395) were independent risk factors of maternal dyslipidemia. Conclusions: The prevalence of dyslipidemia was relatively high in pregnant women and was affected by dietary behaviors. Abnormal lipid levels during pregnancy could affect weight and length at birth, which might be associated with increasing leptin levels in cord blood, and then the weight of infants would be influenced by birth weight.
1. Introduction
The prevalence of obesity in children and adolescents has increased substantially around the world []. The causes of childhood obesity are complex. High birth weight has been shown to be a risk for childhood obesity, which is influenced by the early intrauterine environment. The Developmental Origins of Health and Disease (DOHaD) hypothesis suggests that nutrient excess in utero results in an acquired susceptibility to metabolic disease later in life and the early intrauterine environment is closely related to the metabolism of pregnant women []. At present, there are more reports about the effect of gestational diabetes on the physical development of fetuses. However, there are fewer studies that have focused on abnormal lipid metabolism of pregnant women, and its effect on physical development of fetuses. It is of great practical significance to study the relationship between lipid metabolism of pregnant women and the physical development of fetuses and infants, because of the higher prevalence of dyslipidemia in adulthood in China now. The metabolic pathways underlying early developmental programming in human infants at risk for obesity remain poorly understand. Studies indicate that leptin could affect glucose and lipid metabolism by direct or indirect approaches, through central mechanisms and via metabolically active hormones, such as insulin [,,]. The aim of this study was to explore the effect of blood lipid levels of pregnant women on leptin levels in cord blood, and physical development of fetuses and infants.
The changes in diet and exercise behavior, and the occurrence of complex physiological phenomena during pregnancy, will affect the levels of maternal blood lipid, including total cholesterol (TC), triglyceride, low-density lipoprotein (LDL) and high-density lipoprotein cholesterol. Elevation of blood lipid levels due to pregnancy to a certain extent is physiological []. Nevertheless, when the blood lipid levels surpass the physiological range and develop into dyslipidemia (DLP), adverse pregnancy outcomes such as preeclampsia, prolonged pregnancy, preterm birth and macrosomia will occur [,,]. Current researches’ conclusions about the influencing factors of maternal dyslipidemia are not consistent, so further study is needed to settle targeted preventive measures in the future to reduce the occurrence of maternal dyslipidemia and the incidence of adverse pregnancy outcomes.
The objective of the present study was to explore the influencing factors of women’s dyslipidemia during late gestation and its effects on the physical development of fetuses and infants, as well as the role of leptin in this process, in order to prevent maternal dyslipidemia and ensure the healthy growth and development of infants and young children.
2. Materials and Methods
2.1. Research Objects
A population-based bidirectional cohort study of 338 pairs of pregnant women and newborns was performed between January 2020 and July 2021. The participants in this study were recruited from a third-class A hospital by convenient sampling in Shenyang, China. This study was approved by the Medical Ethics Committee of the Fourth Affiliated Hospital of China Medical University and all participants had provided written informed consent (Reference number: EC-2019-KS-027).
Subjects were included in the study if: (1) they were aged ≥18 years old; (2) they were natural singleton conception; (3) the newborns were live birth. Subjects were excluded from the study if: (1) they were multiple pregnancy; (2) the newborns were birth defects and stillbirth; (3) they suffered from acute and chronic infectious diseases, tumors, cardiovascular diseases or diabetes before pregnancy; (4) they had mental and intellectual disabilities.
2.2. Research Methods
The basic information of pregnant women including general demographic characteristics, dietary frequency, dietary habits, exercise and sleep conditions was gathered by the trained pediatricians through face-to-face surveys using questionnaires, while the standard height and weight measuring instrument was used to measure the height and weight of pregnant women by professionals. Calculated body mass index (BMI) was based on these parameters: BMI = weight (Kg)/height2 (m)2.
Diet-related information included the following aspects: (1) Main food intake frequencies included grains, meats, milk products, soy products, seafoods, vegetables, fruits, etc. (2) Snack intake frequencies included canned food, fried food, nuts, sweets, puffed food, beverages, etc. (3) Eating habits included breakfast, often to eat food before going to bed, whether to eat on time, meals per day, taste, types of drinking water, etc. Definition of snack intake frequencies was as follows: 4–5 times per week was regularly, 2–3 times per week was occasionally, and ≤1 time per week was barely.
Fasting serum lipids: We informed pregnant women to fast for 12 h before getting up in the morning for blood sampling. TC, TG, HDL and LDL levels were detected by a fully automated biochemical analyzer (Siemens ADVIA2400). The abnormal lipid levels were evaluated by the Williams Obstetrics when TC, TG and LDL were, respectively, higher than 7.73 mmol/L, 4.31 mmol/L and 4.76 mmol/L, and HDL was lower than 1.34 mmol/L []. Pregnant women were diagnosed with dyslipidemia if any one of the above four blood lipids was abnormal. Pregnant women with dyslipidemia were divided into the case group, and the others were divided into the control group.
The birth weight (kg) and birth length (cm) of newborns were gathered from delivery records, and then the height (cm) and weight (kg) of infants at six months and one year old were followed up by the trained pediatricians. We divided newborns into large-for-gestational-age and appropriate for gestational age according to the growth reference standards of newborns’ birth weight of different gestational ages in China. Large-for-gestational-age infants were identified when birth weight was >90th percentile standardized birth weight [].
Cord blood samples obtained from umbilical veins were processed within one hour after birth. Serum was separated by centrifugation and stored at −80 °C until assayed. Leptin in 57 random neonatal cord blood samples was detected by ELISA kit (R&D Systems, Inc., Shanghai, China).
2.3. Statistical Analysis
Data management and analysis were performed using SPSS 22.0. Categorical variables were expressed as n (%), chi-squared test or fisher exact test was used to compare differences between groups. Normality tests for continuous variables were conducted. Non-normality variables were expressed as median (quartiles), and the Mann–Whitney U test was used to compare differences between groups. Correlation between two continuous variables was tested by Partial correlation. The logistic regression analysis was used to assess the risk factors of maternal dyslipidemia. The significance level of the p value was set at 0.05.
3. Results
A total of 338 pairs of pregnant women and infants participated in this study. The age (29.31 ± 3.99 years old), height (162.30 ± 5.33 cm), weight before pregnancy (58.31 ± 9.99 kg) and antenatal weight (74.75 ± 10.54 kg) of pregnant women, the birth weight (3.38 ± 0.41 kg) and birth length (50.58 ± 1.57 cm) of newborns, the weight (8.75 ± 1.07 kg) and height (69.34 ± 2.77 cm) of infants at six months, and the weight (10.36 ± 1.15 kg) and height (77.10 ± 2.70 cm) of infants at one year old are shown in Table 1.
Table 1.
The basic information of pregnant women and the height and weight of newborns and infants.
According to the Williams Obstetrics, the overall abnormal rates of TC, TG, HDL-c, LDL-c of pregnant women were 7.1%, 23.4%, 1.7%, 6.4%. The prevalence of dyslipidemia was 31.5% under the standards that one of the above was abnormal. Meanwhile, the prevalence rate of maternal dyslipidemia was 5.2% as per self-report, far lower than 31.5% (p < 0.001), as shown in Table 2.
Table 2.
The detection rates of abnormal blood lipids of pregnant women.
The median levels of TG and TG/HDL ratio were higher in LGA newborns; infants’ height and weight at six months and one year old were higher in LGA newborns than in appropriate for gestational age newborns, shown in Table 3.
Table 3.
Comparison of blood lipid levels of pregnant women and the weight and height of infants in LGA and appropriate for gestational age groups (median, quartiles).
The HDL levels were negatively related to the weight and height of infants at six months in the case of controlling birth weight and birth length (rs = −0.157, p = 0.017; rs = −0.144, p = 0.029, respectively), while other blood lipid levels had nothing to do with the weight and height of infants in the case of controlling birth weight and birth length (p > 0.05). Birth weight was positively related to infants’ height and weight at six months and one year old (rs = 0.322, p < 0.001; rs = 0.344, p < 0.001; rs = 290, p < 0.001; rs = 0.316, p < 0.001, respectively), shown in Table 4.
Table 4.
Correlation between blood lipid levels of pregnant women, birth weight and the height and weight of infants.
There was a positive correlation between leptin in cord blood and TG levels of pregnant women in the third trimester of pregnancy (p = 0.025), shown in Figure 1, while the leptin had nothing to do with TC levels, HDL-c levels, LDL-c levels or the TC/HDL ratio, TG/HDL ratio, or LDL/HDL ratio (p > 0.05, not shown in figures below).
Figure 1.
Correlation between leptin in cord blood and TG levels of pregnant women.
Leptin in cord blood was positively related to newborns’ birth weight (p < 0.001), shown in Figure 2, but was not directly related to infants’ weight at six months and one year old (p > 0.05, not shown in figures below).
Figure 2.
Correlation between leptin in cord blood and the birth weight.
Compared with the control group, the proportion of pregnant women whose age was higher than 30 years old, family financial status was well, or weight gain was excessive during pregnancy was higher in the case group (44.1% vs. 38.1%; 10.8% vs. 5.4%; 38.7% vs. 33.2%, respectively), and the proportion of passive smoking before or after pregnancy was lower in the case group (41.9% vs. 46.0%; 28.0% vs. 32.7%, respectively). None of the differences above were statistically significant (p > 0.05). There was no significant difference in the proportion of pregnant women with family history of diabetes or hypertension between the control group and the case group (p > 0.05), shown in Table 5.
Table 5.
Comparison of the basic situation of pregnant women in the control and case groups (n, %).
Compared with the control group, the intake frequencies of common food, such as coarse grain, vegetables, fruits, soy products, and milk products, greater than or equal to 1 time/day for pregnant women during pregnancy were a bit higher, while the intake frequencies of lean meat and eggs greater than or equal to 1 time/day and of seafoods and liver greater than or equal to 4 times/week were a bit lower in the case group. None of the differences above were statistically significant (p > 0.05), as shown in Table 6.
Table 6.
Comparison of the common food intake frequencies of women during pregnancy between the control and case groups (n, %).
The ‘barely intake’ frequencies of canned food, barbecue, fried food, puffed food, beverages and coffee of pregnant women during pregnancy between the control and case groups were quite unanimous; all of them were higher than 85% (p > 0.05). The ‘barely intake’ frequencies of sweets and the ‘occasionally or regularly intake’ frequencies of nuts were around 60% in both control and case groups (p > 0.05). The ‘regularly intake’ frequencies of health products and the proportion of vitamin D supplement were between 71% and 81% in both control and case groups (p > 0.05), as shown in Table 7.
Table 7.
Comparison of the snack intake frequencies of women during pregnancy between the control and case groups (n, %).
Compared with the control group, the proportion of pregnant women who had equal to or more than three meals a day or who liked to eat lightly flavored food during pregnancy was higher in the case group (46.3% vs. 28.2%; 78.5% vs. 65.8%, p < 0.05). There were no statistically significant differences in eating habits including breakfast, often eating food before going to bed, eating on time, other tastes, and types of drinking water between the control and case groups, as shown in Table 8.
Table 8.
Comparison of the eating and drinking habits of women during pregnancy between the control and case groups (n, %).
Compared with the control group, the proportion of pregnant women who had an elevator at home, watched TV more than 2 h per day, and played mobile more than 3 h per day were higher in the case group. None of the differences above were statistically significant (p > 0.05). Furthermore, ways to go to work, exercise time per day, liking exercise before or after pregnancy, and sleep conditions between the control and case groups were about the same (p < 0.05), as shown in Table 9.
Table 9.
Comparison of pregnant women’s exercise and sleep conditions between the control and case groups (n, %).
Variables with a p value less than 0.05 in the univariate analysis were included in the logistic regression analysis. The result showed that having greater than or equal to four meals a day (OR = 6.552, 95%CI = 1.014–42.338) and liking to eat lightly flavored food during pregnancy (OR = 1.887, 95%CI = 1.048–3.395) were independent risk factors of maternal dyslipidemia, as shown in Table 10.
Table 10.
Logistic regression analysis of the impact factors of maternal dyslipidemia.
4. Discussion
We found the prevalence rate of maternal dyslipidemia was 31.5% according to the Williams Obstetrics. A previous study showed that the detection rates of maternal dyslipidemia varies greatly by different criteria []. This was consistent with our findings as we found the prevalence rate of maternal dyslipidemia was 5.2% by self-report, obviously lower than 31.5%. We concluded that current society often ignores abnormal blood lipid levels during pregnancy as the self-report rate of dyslipidemia was obviously lower. This phenomenon should arouse our attention and health education in this field should be strengthened from now on.
We found birth weight was affected by abnormal TG levels of pregnant women, which agreed with the results of many studies [,,]. In our study, the median levels of TG/HDL ratio were higher in LGA newborns, which agreed with the study that found the TG/HDL ratio showed an obvious dose-dependent relationship with the occurrence of macrosomia []. Consistent with our result, most studies had not found relationships between maternal serum TC and LDL levels and birth weight [,]. Weight in early life was highly associated with weight and quality of life in children, adolescents and adults [,,]. We concluded that TG levels in the third trimester of pregnancy could influence infants’ height and weight indirectly through the influence of birth weight, as the birth weight was positively related to infants’ height and weight at six months and one year old. The number of adipocytes would no longer decrease once they were formed, leading to obesity in children at a younger age, which could represent a hidden danger of being overweight or obese in the future []. Therefore, blood lipid levels of pregnant women should be as much a concern during pregnancy as blood sugar levels.
Leptin could lead to an increase in triglyceride hydrolysis and a suppression of lipogenesis and in vivo studies have obviously demonstrated that leptin can reduce body fat mass []. Our study showed that leptin in cord blood was positively correlated with the maternal serum TG levels in the third trimester of pregnancy and birth weight of fetuses, but was not directly related to infants’ weight at six months and one year old, consistent with Hauguel-de Mouzon, S.’s findings []. This indicates that high TG levels in the third trimester of pregnancy would promote the synthesis of leptin in mothers, and then it would be transmitted into the umbilical cord blood, which would eventually have a direct impact on the growth and development of fetuses. Later, the leptin in the cord blood would indirectly affect the physical development of infants after birth as birth weight was positively related to infants’ height and weight at six months and one year old. The formation of leptin receptors in fetuses could be influenced by the leptin in cord blood, therefore, the leptin receptor gene was considered a biological pathway related to childhood obesity development [,].
The influencing factors of gestational dyslipidemia in the third trimester of pregnancy were explored. Studies have reported that the maternal lipid levels were affected by maternal age, BMI before pregnancy and weight gain during pregnancy [,,]. However, these relationships were not found in our study. Therefore, the baseline information of the two groups of pregnant women was consistent. A nutrient-rich maternal diet during pregnancy was essential to pregnant womens’ health and fetuses’ development []. However, diets with high sugar, high saturated fat and an unreasonable proportion of processed food might increase the risk of adverse pregnancy outcomes [,,]. Interestingly, the results of this study showed no relationship between maternal dyslipidemia and the food intake frequencies or the habit of eating and drinking a lot. We could see the ‘barely intake’ frequencies of relatively unhealthy food, such as canned food, barbecue, fried food, puffed food, beverages and coffee, were higher than 85% in both control and case groups of pregnant women. The dietary habits of pregnant women were healthy while they tended to eat breakfast regularly, eat meals on time, drink boiled water other than sweet drinks, and so on. The vigorous propaganda about the hazards of high sugar, high saturated fat and processed food and the self-protection awareness of pregnant women might explain this phenomenon. Meanwhile, there were no statistically significant differences in exercise and sleep conditions of pregnant women between the control and case groups, however, we still found they tended to spend more time on TV and phones and less time doing exercise on the whole. As exercise and sleep conditions could influence blood lipid levels, this phenomenon should arouse our attention [,].
Logistic regression analysis showed that having greater than or equal to four meals a day and liking to eat lightly flavored food during pregnancy were independent risk factors for maternal dyslipidemia in the third trimester of pregnancy. Although liking to eat lightly flavored food during pregnancy was good for health, it might lead to a lack of protein and excessive carbohydrate intake. If the energy exceeded the body’s needs, carbohydrate-decomposed sugar would be converted into fat in the liver, leading to increased blood lipid levels in pregnant women [,]. Our results showed that the intake frequency of staple foods, vegetables and fruits of at least once a day reached around 80%, while the intake frequency of lean meat, eggs and milk products of at least once a day was only about 50%. Furthermore, the intake frequencies of seafoods and liver were not enough either. The digestive system would stimulate the body to eat more carbohydrates or increase the number of meals if the intake of protein and fat was insufficient, as they could bring a feeling of fullness and prolong the emptying time of the stomach [,,]. Eating a light diet may reduce satiety, and lead to an increase in the number of meals and excessive intake of carbohydrates, which will eventually lead to maternal dyslipidemia. Thus, we should strengthen the guidance of dietary balance during pregnancy to prevent the occurrence of maternal dyslipidemia in the future.
Our study indicated that there was a positive relationship of maternal dyslipidemia during late gestation and the birth index and infants’ development as it was a population-based bidirectional cohort study. However, the follow-up bias was inevitable. Our research showed that the number of meals per day and preferring lightly flavored food during pregnancy might be risk factors for maternal dyslipidemia. Another limitation of our investigation was that the intake of various foods during pregnancy was not quantified, and it was impossible to compare the energy supply proportions of the three major macronutrients.
5. Conclusions
Transient mild dyslipidemia during pregnancy could steadily return to normal after delivery, while more serious dyslipidemia was difficult to correct []. Dyslipidemia in pregnant women could affect birth weight by increasing leptin levels in cord blood, and then influencing the physical development of young children. Thus, we should strengthen the monitoring of blood lipid levels of women during pregnancy. The habits of diet during pregnancy were basically reasonable under vigorous publicity, but the implementation of dietary balance still needed more guidance.
Author Contributions
C.L.: Conceptualization; Formal analysis; Writing—original draft; X.L.: Investigation; Validation; D.W. (Dan Wu): Investigation; Validation; Q.C.: Investigation; Validation; Z.X.: Investigation; Validation; D.W. (Deliang Wen): Investigation; Validation; L.Z.: Conceptualization; Writing—review & editing; L.J.: Conceptualization; Writing—review & editing. All authors have read and agreed to the published version of the manuscript.
Funding
This research was supported by the National Natural Science Foundation of China (grant number: 82073575 and 81673190).
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Medical Ethics Committee of the Fourth Affiliated Hospital of China Medical University (Reference number: EC-2019-KS-027).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
All datasets generated during and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.
Acknowledgments
We thank for the cooperation from the trained pediatricians (Shuangshuang Zhang).
Conflicts of Interest
The authors declare no conflict of interest.
References
- Ng, M.; Fleming, T.; Robinson, M.; Thomson, B.; Graetz, N.; Margono, C.; Mullany, E.C.; Biryukov, S.; Abbafati, C.; Abera, S.F.; et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014, 384, 766–781. [Google Scholar] [CrossRef] [Green Version]
- Friedman, J.E. Obesity and Gestational Diabetes Mellitus Pathways for Programming in Mouse, Monkey, and Man-Where Do We Go Next? The 2014 Norbert Freinkel Award Lecture. Diabetes Care 2015, 38, 1402–1411. [Google Scholar] [CrossRef] [Green Version]
- Bornstein, S.R.; Abu-Asab, M.; Glasow, A.; Path, G.; Hauner, H.; Tsokos, M.; Chrousos, G.P.; Scherbaum, W.A. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes 2000, 49, 532–538. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bamshad, M.; Aoki, V.T.; Adkison, M.G.; Warren, W.S.; Bartness, T.J. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am. J. Physiol. 1998, 275, R291–R299. [Google Scholar] [CrossRef] [PubMed]
- Crume, T.L.; Shapiro, A.L.; Brinton, J.T.; Glueck, D.H.; Martinez, M.; Kohn, M.; Harrod, C.; Friedman, J.E.; Dabelea, D. Maternal fuels and metabolic measures during pregnancy and neonatal body composition: The healthy start study. J. Clin. Endocrinol. Metab. 2015, 100, 1672–1680. [Google Scholar] [CrossRef] [Green Version]
- Ghio, A.; Bertolotto, A.; Resi, V.; Volpe, L.; Di Cianni, G. Triglyceride metabolism in pregnancy. Adv. Clin. Chem. 2011, 55, 133–153. [Google Scholar] [CrossRef] [PubMed]
- Ryckman, K.K.; Spracklen, C.N.; Smith, C.J.; Robinson, J.G.; Saftlas, A.F. Maternal lipid levels during pregnancy and gestational diabetes: A systematic review and meta-analysis. BJOG 2015, 122, 643–651. [Google Scholar] [CrossRef]
- Wang, C.; Zhu, W.; Wei, Y.; Su, R.; Feng, H.; Hadar, E.; Hod, M.; Yang, H. The associations between early pregnancy lipid profiles and pregnancy outcomes. J. Perinatol. 2017, 37, 127–133. [Google Scholar] [CrossRef]
- Jin, W.Y.; Lin, S.L.; Hou, R.L.; Chen, X.Y.; Han, T.; Jin, Y.; Tang, L.; Zhu, Z.W.; Zhao, Z.Y. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: A population-based study from China. BMC Pregnancy Childb. 2016, 16, 60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cunningham, F.G.; Leveno, K.J.; Bloom, S.L.; Spong, C.Y.; Dashe, J.S.; Hoffman, B.L.; Casey, B.M. Williams Obstetrics, 24th ed.; Mc-Graw-Hill: New York, NY, USA, 2014; p. 1291. [Google Scholar]
- The growth reference standards and curves of birth weight, length and head circumference of newborns of different gestational ages in China. Chin. J. Pediatr. 2020, 58, 738–746. [CrossRef]
- Feitosa, A.C.R.; Barreto, L.T.; da Silva, I.M.; da Silva, F.F.; Feitosa, G.S. Impact of the Use of Different Diagnostic Criteria in the Prevalence of Dyslipidemia in Pregnant Women. Arq. Bras. Cardiol. 2017, 109, 30–38. [Google Scholar] [CrossRef]
- Wang, X.X.; Guan, Q.B.; Zhao, J.J.; Yang, F.F.; Yuan, Z.S.; Yin, Y.C.; Fang, R.; Liu, L.W.; Zuo, C.T.; Gao, L. Association of maternal serum lipids at late gestation with the risk of neonatal macrosomia in women without diabetes mellitus. Lipids Health Dis. 2018, 17, 78. [Google Scholar] [CrossRef] [Green Version]
- Herrera-Martinez, A.D.; Ortega, R.P.; Opazo, R.B.; Moreno-Moreno, P.; Puerta, M.J.M.; Galvez-Moreno, M.A. Hyperlipidemia during gestational diabetes and its relation with maternal and offspring complications. Nutr. Hosp. 2018, 35, 698–706. [Google Scholar] [CrossRef]
- Vrijkotte, T.G.; Krukziener, N.; Hutten, B.A.; Vollebregt, K.C.; van Eijsden, M.; Twickler, M.B. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: The ABCD study. J. Clin. Endocrinol. Metab. 2012, 97, 3917–3925. [Google Scholar] [CrossRef]
- Yu, M.R.; Wang, W.T.; Wang, H. The Late-Gestational Triglyceride to High-Density Lipoprotein Cholesterol Ratio Is Associated with Neonatal Macrosomia in Women without Diabetes Mellitus. Int. J. Endocrinol. 2020, 2020, 7250287. [Google Scholar] [CrossRef] [PubMed]
- Hegelund, E.R.; Wimmelmann, C.L.; Strizzi, J.M.; Folker, A.P.; Mortensen, E.L.; Flensborg-Madsen, T. Birth weight and quality of life in midlife: A 50-year follow-up study of 2079 individuals in Denmark. Qual. Life Res. 2020, 29, 1047–1054. [Google Scholar] [CrossRef] [PubMed]
- Eide, M.G.; Oyen, N.; Skjaerven, R.; Nilsen, S.T.; Bjerkedal, T.; Tell, G.S. Size at birth and gestational age as predictors of adult height and weight. Epidemiology 2005, 16, 175–181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhao, Y.; Wang, S.F.; Mu, M.; Sheng, J. Birth weight and overweight/obesity in adults: A meta-analysis. Eur. J. Pediatr. 2012, 171, 1737–1746. [Google Scholar] [CrossRef] [PubMed]
- Zhou, J.; Zeng, L.; Wang, D.; Li, C.; Liu, Y.; Yan, H.; Xiao, Y. Effects of birth weight on body composition and overweight/obesity at early school age. Clin. Nutr. 2020, 39, 1778–1784. [Google Scholar] [CrossRef] [PubMed]
- Harris, R.B. Direct and indirect effects of leptin on adipocyte metabolism. Biochim. Biophys. Acta 2014, 1842, 414–423. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hauguel-de Mouzon, S.; Lepercq, J.; Catalano, P. The known and unknown of leptin in pregnancy. Am. J. Obs. Gynecol. 2006, 194, 1537–1545. [Google Scholar] [CrossRef] [PubMed]
- Marginean, C.; Marginean, C.O.; Iancu, M.; Melit, L.E.; Tripon, F.; Banescu, C. The FTO rs9939609 and LEPR rs1137101 mothers-newborns gene polymorphisms and maternal fat mass index effects on anthropometric characteristics in newborns: A cross-sectional study on mothers-newborns gene polymorphisms-The FTO-LEPR Study (STROBE-compliant article). Medicine 2016, 95, e5551. [Google Scholar] [CrossRef] [PubMed]
- Mǎrginean, C.O.; Mǎrginean, C.; Meliţ, L.E. New Insights Regarding Genetic Aspects of Childhood Obesity: A Minireview. Front. Pediatr. 2018, 6, 271. [Google Scholar] [CrossRef] [Green Version]
- Sasaki, H.; Arata, N.; Tomotaki, A.; Yamamoto-Hanada, K.; Mezawa, H.; Konishi, M.; Ishitsuka, K.; Saito-Abe, M.; Sato, M.; Nishizato, M.; et al. Time course of metabolic status in pregnant women: The Japan Environment and Children’s Study. J. Diabetes Investig. 2020, 11, 1318–1325. [Google Scholar] [CrossRef] [Green Version]
- Shen, H.; Liu, X.H.; Chen, Y.; He, B.W.; Cheng, W.W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: A prospective longitudinal cohort study. BMJ Open 2016, 6, e013509. [Google Scholar] [CrossRef] [Green Version]
- Jiang, L.L.; Lin, J.; Yan, J.Y.; Lin, X.Q.; Han, Q.; Zhang, H.L. Prepregnancy body mass indexes are associated with perinatal outcomes in females with preeclampsia. Exp. Med. 2020, 20, 500–504. [Google Scholar] [CrossRef] [Green Version]
- Lowensohn, R.I.; Stadler, D.D.; Naze, C. Current Concepts of Maternal Nutrition. Obs. Gynecol. Surv. 2016, 71, 413–426. [Google Scholar] [CrossRef] [Green Version]
- Rohatgi, K.W.; Tinius, R.A.; Cade, W.T.; Steele, E.M.; Cahill, A.G.; Parra, D.C. Relationships between consumption of ultra-processed foods, gestational weight gain and neonatal outcomes in a sample of US pregnant women. PeerJ 2017, 5, e4091. [Google Scholar] [CrossRef] [PubMed]
- Petherick, E.S.; Goran, M.I.; Wright, J. Relationship between artificially sweetened and sugar-sweetened cola beverage consumption during pregnancy and preterm delivery in a multi-ethnic cohort: Analysis of the Born in Bradford cohort study. Eur. J. Clin. Nutr. 2014, 68, 404–407. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Park, S.; Kim, M.Y.; Baik, S.H.; Woo, J.T.; Kwon, Y.J.; Daily, J.W.; Park, Y.M.; Yang, J.H.; Kim, S.H. Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI. Eur. J. Clin. Nutr. 2013, 67, 196–201. [Google Scholar] [CrossRef] [Green Version]
- Clark, E.; Isler, C.; Strickland, D.; McMillan, A.G.; Fang, X.; Kuehn, D.; Ravisankar, S.; Strom, C.; May, L.E. Influence of aerobic exercise on maternal lipid levels and offspring morphometrics. Int. J. Obes. 2019, 43, 594–602. [Google Scholar] [CrossRef] [PubMed]
- Koyac, U.; Jasper, E.A.; Smith, C.J.; Baer, R.J.; Bedell, B.; Donovan, B.M.; Weathers, N.; Zmrzljak, U.P.; Jeffiffe-Pawlowski, L.L.; Rozman, D.; et al. The Association of Polymorphisms in Circadian Clock and Lipid Metabolism Genes With 2nd Trimester Lipid Levels and Preterm Birth. Front. Genet. 2019, 10, 540. [Google Scholar] [CrossRef] [Green Version]
- Alwahsh, S.M.; Gebhardt, R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch. Toxicol. 2017, 91, 1545–1563. [Google Scholar] [CrossRef] [PubMed]
- Hydes, T.J.; Ravi, S.; Loomba, R.; Gray, M.E. Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. Clin. Mol. Hepatol. 2020, 26, 383–400. [Google Scholar] [CrossRef]
- Soenen, S.; Westerterp-Plantenga, M.S. Proteins and satiety: Implications for weight management. Curr. Opin. Clin. Nutr. 2008, 11, 747–751. [Google Scholar] [CrossRef] [Green Version]
- Soenen, S.; Hochstenbach-Waelen, A.; Westerterp-Plantenga, M.S. Efficacy of alpha-Lactalbumin and Milk Protein on Weight Loss and Body Composition During Energy Restriction. Obesity 2011, 19, 370–379. [Google Scholar] [CrossRef] [PubMed]
- Fernandez-Sanchez, A.; Madrigal-Santillan, E.; Bautista, M.; Esquivel-Soto, J.; Morales-Gonzalez, A.; Esquivel-Chirino, C.; Durante-Montiel, I.; Sanchez-Rivera, G.; Valadez-Vega, C.; Morales-Gonzalez, J.A. Inflammation, Oxidative Stress, and Obesity. Int. J. Mol. Sci. 2011, 12, 3117–3132. [Google Scholar] [CrossRef] [Green Version]
- Adank, M.C.; Benschop, L.; Peterbroers, K.R.; Smak Gregoor, A.M.; Kors, A.W.; Mulder, M.T.; Schalekamp-Timmermans, S.; Roeters Van Lennep, J.E.; Steegers, E.A.P. Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long term postpartum? Am. J. Obs. Gynecol. 2019, 221, 150.e1–150.e13. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).